Four unloved healthcare stocks that stand to benefit from ageing populations

Top picks for long-term care

clock • 1 min read

Claire Shaw, manager of the OYSTER European Mid & Small Cap fund at SYZ Asset Management, picks four healthcare stocks which stand to benefit from a more ageing population.

Claire Shaw, manager of the OYSTER European Mid & Small Cap fund at SYZ Asset Management, picks four healthcare stocks which stand to benefit from a more ageing population. "The ailing healthcare sector was one of Europe's worst performing sectors - over the last year, the MSCI Europe Health Care Index underperformed the MSCI Europe Index by 10.13. "Regulatory changes and costly infrastructure spending have contributed to shrinking margins and rising costs. Why healthcare stocks remain attractive despite drug pricing pressure "While there are headwinds, there are also plenty of ...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

‘Dedicated specialists’

James Baxter-Derrington
clock 06 April 2023 • 4 min read
European private equity yet to spend €270bn worth of capital

European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock 04 January 2023 • 1 min read
Early-stage biopharma: An opportunity for strategic investment

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot